Terms: = Uterine cancer AND LEF1, TCF1ALPHA, 51176, ENSG00000138795, Q9UJU2, DKFZp586H0919 AND Treatment
4 results:
1. Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis.
Brown M; Leon A; Kedzierska K; Moore C; Belnoue-Davis HL; Flach S; Lydon JP; DeMayo FJ; Lewis A; Bosse T; Tomlinson I; Church DN
EMBO Mol Med; 2023 Oct; 15(10):e17094. PubMed ID: 37589076
[TBL] [Abstract] [Full Text] [Related]
2. A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer.
He WP; Chen YY; Wu LX; Guo YY; You ZS; Yang GF
Front Immunol; 2022; 13():1018544. PubMed ID: 36466815
[TBL] [Abstract] [Full Text] [Related]
3. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract] [Full Text] [Related]
4. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
